The Rosen Law Firm is urging investors of Eagle Bancorp, Inc. (NASDAQ: EGBN) to inquire about a securities class action investigation announced on June 23, 2025. The announcement aims to inform shareholders of potential legal claims related to their investments.

The CEO of Travere Therapeutics has recently sold $398,000 worth of company stock, according to a report by Investing Us. This significant insider transaction highlights executive activity within the company.

Pomerantz LLP has launched an investigation into Gorilla Technology Group, Inc., focusing on potential securities fraud and unlawful business practices involving the company’s officers and directors. Investors are urged to contact the law firm as the inquiry unfolds.

Investors in Aehr Test Systems are being notified of a class action lawsuit alleging securities fraud related to undisclosed order delays and overstated financial prospects. The lawsuit covers investors affected between January 9, 2024, and March 24, 2024, with a lead plaintiff deadline of February 3, 2025.